CRMAX
Price
$11.37
Change
+$0.84 (+7.98%)
Updated
Feb 3 closing price
Net Assets
145.05M
VEXMX
Price
$163.24
Change
+$2.65 (+1.65%)
Updated
Feb 3 closing price
Net Assets
82.12B
Interact to see
Advertisement

CRMAX vs VEXMX

Header iconCRMAX vs VEXMX Comparison
Open Charts CRMAX vs VEXMXBanner chart's image
CRM Small/Mid Cap Value I
Price$11.37
Change+$0.84 (+7.98%)
VolumeN/A
Net Assets145.05M
Vanguard Extended Market Index Investor
Price$163.24
Change+$2.65 (+1.65%)
VolumeN/A
Net Assets82.12B
CRMAX vs VEXMX Comparison Chart in %
View a ticker or compare two or three
VS
CRMAX vs. VEXMX commentary
Feb 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRMAX is a Buy and VEXMX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VEXMX has more cash in the bank: 82.1B vs. CRMAX (145M). VEXMX pays higher dividends than CRMAX: VEXMX (0.98) vs CRMAX (0.28). CRMAX was incepted earlier than VEXMX: CRMAX (21 years) vs VEXMX (38 years). CRMAX (1.24) is less costly to investors than VEXMX (0.19). CRMAX is a more actively managed with annual turnover of: 46.00 vs. VEXMX (11.00). CRMAX has a lower initial minimum investment than VEXMX: CRMAX (2500) vs VEXMX (3000). VEXMX annual gain was more profitable for investors over the last year : 9.27 vs. CRMAX (5.67). VEXMX return over 5 years is better than : 21.26 vs. CRMAX (-12.98).
CRMAXVEXMXCRMAX / VEXMX
Total Expense Ratio1.240.19653%
Annual Report Gross Expense Ratio1.240.19653%
Fund Existence21 years38 years-
Gain YTD6.3612.828225%
Front LoadN/AN/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets145M82.1B0%
Annual Yield % from dividends0.280.9829%
Returns for 1 year5.679.2761%
Returns for 3 years8.4943.5619%
Returns for 5 years-12.9821.26-61%
Returns for 10 years7.77203.314%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GCIAX18.810.10
+0.53%
Goldman Sachs Intl Eq Insghts A
ANVRX10.970.04
+0.37%
American Century Non-US Intrs Val R
IVGAX20.520.03
+0.15%
VY® Invesco Growth and Income A
PHPSX29.220.04
+0.14%
ProFunds Pharmaceuticals UltraSector Svc
GLCTX30.75-0.64
-2.04%
Goldman Sachs Large Cap Gr Insghts Inv